On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Gregory A. Daniels

ResearcherPublications, citations & collaboration network

Gregory A. Daniels is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Gregory A. Daniels have?

ScholarIQindexed works

Gregory A. Daniels has 261 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Gregory A. Daniels have?

ScholarIQcitation count

Gregory A. Daniels has 18,180 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Gregory A. Daniels?

ScholarIQh-index

Gregory A. Daniels has an h-index of 43 in OpenAlex.

What is the i10-index of Gregory A. Daniels?

ScholarIQi10-index

Gregory A. Daniels has an i10-index of 77 in OpenAlex.

What is the ORCID of Gregory A. Daniels?

ScholarIQorcid

The ORCID for Gregory A. Daniels is on the source record.

What is the OpenAlex record for Gregory A. Daniels?

ScholarIQopenalex

The OpenAlex for Gregory A. Daniels is on the source record.

What are the most-cited papers on Gregory A. Daniels?

ScholarIQmost cited works
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
Molecular Cancer Therapeutics. 20172,408 CitationsOPEN ACCESS
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Christopher K. Bichakjian, Thomas Olencki, Sumaira Z. Aasi, Murad Alam, James Andersen, Rachel Blitzblau, Glen M. Bowen, Carlo M. Contreras, Gregory A. Daniels, Roy H. Decker, Jeffrey M. Farma, K.A. Fisher, Brian Gastman, Karthik Ghosh, Roy C. Grekin, Kenneth Grossman, Alan L. Ho, Karl D. Lewis, Manisha J. Loss, Daniel D. Lydiatt, Jane L. Messina, Kishwer S. Nehal, Paul Nghiem, Igor Puzanov, Chrysalyne D. Schmults, Ashok R. Shaha, Valencia D. Thomas, Yaohui G. Xu, John A. Zic, K Hoffmann, Anita M. Engh
Journal of the National Comprehensive Cancer Network. 2018316 CitationsOPEN ACCESS
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
Assuntina G. Sacco, Ruifeng Chen, Francis P. Worden, Deborah Jean Lee Wong, Douglas R. Adkins, Paul Swiecicki, Wanxing Chai‐Ho, Peter Oppelt, Debanjali Ghosh, Julie Bykowski, Alfredo Molinolo, Emily Pittman, Mónica V. Estrada, Kathryn A. Gold, Gregory A. Daniels, Scott M. Lippman, Amanda Natsuhara, Karen Messer, Ezra E.W. Cohen
The Lancet Oncology. 2021262 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account